Immune Checkpoints and Innovative Therapies in Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Checkpoints and Innovative Therapies in Glioblastoma

Published:2018-10-23 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Romani Massimo,Pistillo Maria Pia,Carosio Roberta,Morabito Anna,Banelli Barbara

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Compagnia di San Paolo

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference64 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med.,2005

2. Beyond alkylating agents for gliomas: quo vadimus?;Puduvalli;Am Soc Clin Oncol Educ Book,2017

3. Investigational new drugs for brain cancer;Staedtke;Expert Opin Invest Drugs,2016

4. Targeted therapeutics in patients with high-grade gliomas: past, present, and future;Chen;Curr Treat Options Oncol.,2016

5. Glioblastoma targeted therapy: updated approaches from recent biological insights;Touat;Ann Oncol.,2017

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics;Computational and Structural Biotechnology Journal;2024-12

2. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

3. Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment;Journal of Advanced Research;2024-08

4. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma;Pharmaceutics;2024-06-28

5. A novel prognostic risk-scoring system based on m5C methylation regulator-mediated patterns for glioma patients;Molecular Therapy: Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3